OCTAVIAN SHARP: Open Payments
NPI 1184938201 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 18 payments from 9 companies in 2025. Trend: 2023 $1,820 · 2024 $161 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $333 |
| Insulet Corporation | 2 | $149 |
| ViiV Healthcare Company | 1 | $118 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Abbott Laboratories | 2 | $38 |
| Exact Sciences Corporation | 2 | $35 |
| Corcept Therapeutics | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| ABBVIE INC. | 1 | $16 |
Products named: OMNIPOD, Wegovy, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit, Ozempic, Korlym, MOUNJARO.
Industry payments across TN — which companies pay providers there.
